Back
Bicara Therapeutics Vs. Argan Industry Stock Comparison
Sell
8
BCAX
Bicara Therapeutics
Last Price:
$10.77
Seasonality Move:
--
Buy
64
AGX
Argan
Last Price:
$148.24
Seasonality Move:
5.82%
Sell
8
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $10.15. The Score for BCAX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $10.15Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight selling pressure.
AGX Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 37.28 | Sell |
Chaikin Money Flow: | -120620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.03 - 14.39) | Sell |
Bollinger Bands (100): | (11.78 - 18.38) | Sell |
AGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.2 | Buy |
Relative Strength Index (14 RSI): | 55.74 | Buy |
Chaikin Money Flow: | 17046 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (115.49 - 132.85) | Buy |
Bollinger Bands (100): | (125.71 - 158.25) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.97 | Sell |
20-day SMA: | 12.23 | Sell |
50-day SMA: | 12.79 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 10.82 | Sell |
20-day EMA: | 11.89 | Sell |
50-day EMA: | 12.95 | Sell |
200-day EMA: | 11.31 | Sell |
AGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.62 | Buy |
20-day SMA: | 126.75 | Buy |
50-day SMA: | 131.59 | Buy |
200-day SMA: | 117.24 | Buy |
8-day EMA: | 132.06 | Buy |
20-day EMA: | 129.12 | Buy |
50-day EMA: | 132 | Buy |
200-day EMA: | 118.3 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
Argan Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.13 per share, an increase this year of $2.73 per share, and an increase next year of $0.72 per share.
Bicara Therapeutics Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Argan Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |